Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MINUSTOSAN 1,5 MG/ML JARABE EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/MINUSTOSAN 1,5 MG/ML JARABE EFG

Approved

STANDARD

MINUSTOSAN 1,5 MG/ML JARABE EFG

Medochemie Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 3, 2021
Approval ID: 7b802d7ff6810b60
Company: Medochemie Limited
Type: Standard

Approval Details

Approval Id: 7b802d7ff6810b60
Drug Cima Aemps Name: MINUSTOSAN 1,5 MG/ML JARABE EFG
Register Number: 84688
Holder Company Name: Medochemie Limited
Marketing Company Name: Medochemie Iberia S.A. Sucursal En Espana
Authorization Date: 2021-06-03
Dosage Form: JARABE
Dose: 1,5 mg/ml
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Medochemie Limited

Active Ingredients

DEXTROMETORFANO HIDROBROMURO

1,5 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 3, 2021

Approval ID

7b802d7ff6810b60

Type

Standard

Back to CIMA-AEMPS Approvals